Lv7
3290 积分 2023-02-22 加入
Real-world comparison of flumatinib and nilotinib as first-line therapy for patients with chronic phase chronic myeloid leukemia: a multicenter retrospective study
1天前
待确认
Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens
1个月前
已完结
Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors
1个月前
已完结
Nephrotoxicity in cancer treatment: An update
1个月前
已完结
Renal Toxicities of Targeted Therapies
1个月前
已完结
Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1
1个月前
已完结
Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors
1个月前
已完结
皖公网安备34019202002308
